COMMUNIQUÉS West-GlobeNewswire

Trevi Therapeutics Announces Upcoming June and July Event Schedule
17/06/2026
NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
17/06/2026
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease RAMAT GAN, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a [...]
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
17/06/2026
~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter of 2026 ~ LEXINGTON [...]
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
17/06/2026
Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and [...]
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
17/06/2026
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development [...]
Des preuves inédites montrent comment un modèle fondé sur l’entrepreneuriat peut réduire l’extrême pauvreté parmi les réfugiés
17/06/2026
De nouvelles études montrent que le programme DREAMS augmente les revenus, l’épargne et la résilience des communautés de réfugiés en Afrique de l’Est La Fondation IKEA a engagé 7,4 millions de dollars pour financer la [...]
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
17/06/2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, June 17, 2026 – Kuros Biosciences (“Kuros” or the “ [...]
IBA strengthens its leadership team to support its growth
17/06/2026
Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine Vandenborre is [...]
IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend
17/06/2026
Louvain-la-Neuve, Belgium, 17 June 2026 - At its Board meeting held yesterday in Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) welcomed two new Board members, acknowledged the departure of outgoing [...]
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
IBA renforce son Conseil d’administration avec deux nominations de premier plan et annonce la date du paiement de son dividende
17/06/2026
Louvain-la-Neuve, Belgique, le 17 juin 2026 - Lors de son Conseil d’administration tenu hier à Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) a approuvé la nomination de nouveaux membres de son Conseil d’ [...]
IBA déploie son équipe de direction pour accompagner son développement
17/06/2026
Olivier Legrain, CEO d'IBA, est nommé Vice-Président du Conseil d'administration d'IBA et Henri de Romrée, Deputy CEO, prend la responsabilité stratégique et opérationnelle de l'ensemble des activités du Groupe. [...]
GuideAI Health Corp. Announces Closing of Business Combination, Subscription Receipt Offering, and Filing of Final Prospectus
17/06/2026
Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. BOSTON, June 16, 2026 (GLOBE [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/06/2026
BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
16/06/2026
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for weight-loss treatment, [...]
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
16/06/2026
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading competitor GraftAssure’s industry-leading reference change value (time-point to time-point [...]
Silexion Therapeutics to Attend BIO International Convention 2026
16/06/2026
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, [...]
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
16/06/2026
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the Toronto Stock [...]
Shopify Announces Results of its 2026 Annual Meeting of Shareholders
16/06/2026
Internet, Everywhere, June 16, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) announced today the results of its annual meeting of shareholders held on June 16, 2026. All director nominees were elected to the [...]

Pages